Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD247 antibody

The Mouse Monoclonal anti-CD247 antibody is suitable to detect CD247 in samples from Human. It has been validated for FACS and EIA.
Catalog No. ABIN1106132
$528.00
Plus shipping costs $50.00
0.1 mL
Shipping to: United States
Will be delivered in 1 Business Day

Quick Overview for CD247 antibody (ABIN1106132)

Target

See all CD247 Antibodies
CD247 (CD247 Molecule (CD247))

Reactivity

  • 92
  • 41
  • 18
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 76
  • 13
  • 5
  • 1
Mouse

Clonality

  • 64
  • 31
Monoclonal

Conjugate

  • 54
  • 7
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
This CD247 antibody is un-conjugated

Application

  • 61
  • 44
  • 36
  • 19
  • 16
  • 16
  • 9
  • 6
  • 2
  • 2
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Enzyme Immunoassay (EIA)

Clone

4D10A6
  • Specificity

    Recognizes CD3

    Cross-Reactivity (Details)

    Species reactivity (tested):Human.

    Isotype

    IgG2a
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Reconstitution

    Restore with 1 mL of sterile deionized water to make the concentration of 0.5 mg/mL in PBS, pH 7.2.
  • Target

    CD247 (CD247 Molecule (CD247))

    Alternative Name

    CD247 / CD3Z

    Background

    CD3 is a component of T cell surface receptor (TCR), it cantains 5 invariable chains: gamma- , delta-, epsilon-, and zeta/eta.Clevers et al. (1988) showed the TCR/CD3 complex consists of either a TCR alpha/beta or TCR gamma/delta heterodimer coexpressed at the cell surface with the invariant subunits,CD3 is responsible for the signal transduction of the TCR.Synonyms: CD3 zeta chain, T-cell receptor T3 zeta chain, T-cell surface glycoprotein CD3 zeta chain, T3Z, TCRZ

    Gene ID

    919

    Pathways

    TCR Signaling, CXCR4-mediated Signaling Events, Ubiquitin Proteasome Pathway
You are here:
Chat with us!